Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaki Terabe

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Seminars in Oncology|May 19, 2012
Strategies to use immune modulators in therapeutic vaccines against cancerJay A Berzofsky, Masaki Terabe, Lauren V Wood
Cancer Immunology, Immunotherapy : CII|November 12, 2003
Role of IL-13 in regulation of anti-tumor immunity and tumor growthMasaki Terabe, Jong Myun Park, Jay A Berzofsky
Methods in Enzymology|January 18, 2020
Complementary approaches to study NKT cells in cancerJay A Berzofsky, Purevdorj B Olkhanud, Masaki Terabe
Frontiers in Immunology|November 13, 2014
NKT cell networks in the regulation of tumor immunityFaith C Robertson, Jay A Berzofsky, Masaki Terabe
Cancer Research|April 19, 2006
Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chainKoji Kawakami, Masaki Terabe, Mariko Kawakami, et al.
Parasitology International|October 8, 2004
Influence of H2 complex and non-H2 genes on progression of cutaneous lesions in mice infected with Leishmania amazonensisMasaki Terabe, Shigeharu Wakana, Ken Katakura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumorsKoji Kawakami, Masaki Terabe, Mitomu Kioi, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2007
Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulationJong Myun Park, Masaki Terabe, Debra D Donaldson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2011
A novel combination immunotherapy for cancer by IL-13Rα2-targeted DNA vaccine and immunotoxin in murine tumor modelsHideyuki Nakashima, Masaki Terabe, Jay A Berzofsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2008
IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosisSangkon Oh, Liyanage P Perera, Masaki Terabe, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Seminars in Oncology|May 19, 2012
Strategies to use immune modulators in therapeutic vaccines against cancerJay A Berzofsky, Masaki Terabe, Lauren V Wood
Cancer Immunology, Immunotherapy : CII|November 12, 2003
Role of IL-13 in regulation of anti-tumor immunity and tumor growthMasaki Terabe, Jong Myun Park, Jay A Berzofsky
Methods in Enzymology|January 18, 2020
Complementary approaches to study NKT cells in cancerJay A Berzofsky, Purevdorj B Olkhanud, Masaki Terabe
Frontiers in Immunology|November 13, 2014
NKT cell networks in the regulation of tumor immunityFaith C Robertson, Jay A Berzofsky, Masaki Terabe
Cancer Research|April 19, 2006
Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chainKoji Kawakami, Masaki Terabe, Mariko Kawakami, et al.
Parasitology International|October 8, 2004
Influence of H2 complex and non-H2 genes on progression of cutaneous lesions in mice infected with Leishmania amazonensisMasaki Terabe, Shigeharu Wakana, Ken Katakura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumorsKoji Kawakami, Masaki Terabe, Mitomu Kioi, et al.
Cancer Immunology, Immunotherapy : CII|November 16, 2007
Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulationJong Myun Park, Masaki Terabe, Debra D Donaldson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2011
A novel combination immunotherapy for cancer by IL-13Rα2-targeted DNA vaccine and immunotoxin in murine tumor modelsHideyuki Nakashima, Masaki Terabe, Jay A Berzofsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2008
IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosisSangkon Oh, Liyanage P Perera, Masaki Terabe, et al.
Pageof 9